Anne Coleman to Recombinant Fusion Proteins
This is a "connection" page, showing publications Anne Coleman has written about Recombinant Fusion Proteins.
Connection Strength
0.239
-
Socioeconomic Disparities in Intravitreal Injection Use and Anti-VEGF Agent Selection: Aflibercept/Ranibizumab Versus Bevacizumab. Clin Ther. 2025 Aug; 47(8):559-565.
Score: 0.239
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.